Pulmonx received FDA pre-market approval for a drug and plans to present its findings at a conference in Boston.
1 report, 1 independent
Updated Jul 30
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Pulmonx received FDA pre-market approval for a drug and plans to present its findings at a conference in Boston.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Pulmonx (United States)
company in Redwood City, United States
Nothing else this week.
- FDA
Related events
- FDA and Pfizer are seeking regulatory approval for their products.
- BioXcel Therapeutics received FDA approval for its drug and announced results from New Haven.
- Amylyx Pharmaceuticals is seeking FDA approval for a new drug treatment.
- The FDA recommended advancement for a new drug application submitted by a company.
- A product was launched in the U.S. market following FDA involvement.
Coverage
Newest first; wire copies grouped- GlobeNewswirePulmonx to Present at the Canaccord Genuity 45th Annual Growth Conference REDWOOD CITY, Calif., July 29, 2025 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx” or the "Company"), a gl